{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:35:49Z","timestamp":1648859749539},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2007,6,29]],"date-time":"2007-06-29T00:00:00Z","timestamp":1183075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00270-007-9113-7","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T14:43:08Z","timestamp":1183041788000},"page":"144-148","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of Superior Vena Cava (SVC) Syndrome and Inferior Vena Cava (IVC) Thrombosis in a Patient with Colorectal Cancer: Combination of SVC Stenting and IVC Filter Placement to Palliate Symptoms and Pave the Way for Port Implantation"],"prefix":"10.1007","volume":"31","author":[{"given":"Alexander","family":"Sauter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Triller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Kickuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,29]]},"reference":[{"key":"9113_CR1","volume-title":"Cancer facts and figures 2006","author":"American Cancer Society","year":"2006","unstructured":"American Cancer Society (2006) Cancer facts and figures 2006. American Cancer Society, Atlanta, GA"},{"key":"9113_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3949\/ccjm.72.2.157","volume":"72","author":"AK Jaffer","year":"2005","unstructured":"Jaffer AK (2005) Issues in anticoagulant therapy: recent trials start to answer the tough questions. Cleve Clin J Med 72:157\u2013163","journal-title":"Cleve Clin J Med"},{"key":"9113_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archinte.164.2.190","volume":"164","author":"HM Otten","year":"2004","unstructured":"Otten HM, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, Prins MH (2004) Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 164:190\u2013194","journal-title":"Arch Intern Med"},{"key":"9113_CR4","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","volume":"343","author":"HT Sorensen","year":"2000","unstructured":"Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846\u20131850","journal-title":"N Engl J Med"},{"key":"9113_CR5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1182\/asheducation-2003.1.520","volume":"1","author":"AI Schafer","year":"2003","unstructured":"Schafer AI, Levine MN, Konkle BA, Kearon C (2003) Thrombotic disorders: diagnosis and treatment. Hematol Am Soc Hematol Educ Program 1:520\u2013539","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"9113_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1188\/04.CJON.289-299","volume":"8","author":"R Gerpen Van","year":"2004","unstructured":"Van Gerpen R, Mast ME (2004) Thromboembolic disorders in cancer. Clin J Oncol Nurs 8:289\u2013299","journal-title":"Clin J Oncol Nurs"},{"key":"9113_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<395::AID-CNCR20>3.0.CO;2-T","volume":"82","author":"SH Kim","year":"1998","unstructured":"Kim SH, Brennan MF, Russo P, Burt ME, Coit DG (1998) The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 82:389\u2013394","journal-title":"Cancer"},{"key":"9113_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0894-7317(98)70128-2","volume":"11","author":"JJ Lee","year":"1998","unstructured":"Lee JJ, Kupfer J, Raissi S, Geller SA, Siegel RJ (1998) Rapid extension of left adrenocortical carcinoma into the right atrium. J Am Soc Echocardiogr 11:86\u201388","journal-title":"J Am Soc Echocardiogr"},{"key":"9113_CR9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.ju.0000045706.35470.1e","volume":"169","author":"A Zisman","year":"2003","unstructured":"Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS (2003) Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 169:909\u2013916","journal-title":"J Urol"},{"key":"9113_CR10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2214\/ajr.177.3.1770585","volume":"177","author":"C Lanciego","year":"2001","unstructured":"Lanciego C, Chacon JL, Julian A, Andrade J, Lopez L, Martinez B, Cruz M, Garcia-Garcia L (2001) Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR 177:585\u2013593","journal-title":"AJR"},{"key":"9113_CR11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s005200000173","volume":"9","author":"PY Marcy","year":"2001","unstructured":"Marcy PY, Magne N, Bentolila F, Drouillard J, Bruneton JN, Descamps B (2001) Superior vena cava obstruction: Is stenting necessary? Support Care Cancer 9:103\u2013107","journal-title":"Support Care Cancer"},{"key":"9113_CR12","unstructured":"Trousseau A (1865) Phlegmasia alba dolens. In: Trousseau A (ed) Clinique medicale de l\u2019Hotel-Dieu de Paris, Vol. 3. Balliere, Paris, pp 654\u2013712"},{"key":"9113_CR13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","volume":"9","author":"T Saphner","year":"1991","unstructured":"Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9:286\u2013294","journal-title":"J Clin Oncol"},{"key":"9113_CR14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1188\/04.CJON.465-469","volume":"8","author":"PH Viale","year":"2004","unstructured":"Viale PH, Schwartz RN (2004) Venous thromboembolism in patients with cancer. Part II. Current treatment strategies. Clin J Oncol Nurs 8:465\u2013469","journal-title":"Clin J Oncol Nurs"},{"issue":"Suppl 1","key":"9113_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.soncn.2005.10.001","volume":"21","author":"RS Cunningham","year":"2005","unstructured":"Cunningham RS (2005) Therapeutic options for the treatment of cancer-associated thrombosis. Semin Oncol Nurs 21(Suppl 1):21\u201340","journal-title":"Semin Oncol Nurs"},{"key":"9113_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V62.1.14.14","volume":"62","author":"FR Rickles","year":"1983","unstructured":"Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau\u2019s syndrome revisited. Blood 62:14\u201331","journal-title":"Blood"},{"key":"9113_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","volume":"78","author":"N. Levitan","year":"1999","unstructured":"Levitan N., Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78:285\u2013291","journal-title":"Medicine (Baltimore)"},{"key":"9113_CR18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/1097-0142(19900215)65:4<885::AID-CNCR2820650410>3.0.CO;2-H","volume":"65","author":"T Kuzel","year":"1990","unstructured":"Kuzel T, Esparaz B, Green D, Kies M (1990) Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 65:885\u2013889","journal-title":"Cancer"},{"key":"9113_CR19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/1097-0142(19890401)63:7<1303::AID-CNCR2820630713>3.0.CO;2-F","volume":"63","author":"SE Feffer","year":"1989","unstructured":"Feffer SE, Carmosino LS, Fox RL (1989) Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer 63:1303\u20131307","journal-title":"Cancer"},{"key":"9113_CR20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF00135874","volume":"8","author":"MC Bertomeu","year":"1990","unstructured":"Bertomeu MC, Gallo S, Lauri D, Levine MN, Orr FW, Buchanan MR (1990) Chemotherapy enhances endothelial cell reactivity to platelets. Clin Exp Metastasis 8:511\u2013518","journal-title":"Clin Exp Metastasis"},{"key":"9113_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0169-5002(93)90182-W","volume":"10","author":"CI Rodrigues","year":"1993","unstructured":"Rodrigues CI, Njo KH, Karim AB (1993) Hypofractionated radiation therapy in the treatment of superior vena cava syndrome. Lung Cancer 10:221\u2013228","journal-title":"Lung Cancer"},{"key":"9113_CR22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1148\/radiology.161.2.3763891","volume":"161","author":"C Charnsangavej","year":"1986","unstructured":"Charnsangavej C, Carrasco CH, Wallace S, Wright KC, Ogawa K, Richli W, Gianturco C (1986) Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 161:295\u2013298","journal-title":"Radiology"},{"key":"9113_CR23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00270-005-0284-9","volume":"29","author":"R Uberoi","year":"2006","unstructured":"Uberoi R (2006) Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Interv Radiol 29:319\u2013322","journal-title":"Cardiovasc Interv Radiol"},{"key":"9113_CR24","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.20578","volume":"101","author":"MJ Wallace","year":"2004","unstructured":"Wallace MJ, Jean JL, Gupta S, Eapen GA, Johnson MM, Ahrar K, Madoff DC, Morello FA, Murthy R, Hicks ME (2004) Use of inferior vena caval filters and survival in patients with malignancy. Cancer 101:1902\u20131907","journal-title":"Cancer"},{"key":"9113_CR25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0741-5214(02)00121-0","volume":"36","author":"BP Jarrett","year":"2002","unstructured":"Jarrett BP, Dougherty MJ, Calligaro KD (2002) Inferior vena cava filters in malignant disease. J Vasc Surg 36:704\u2013707","journal-title":"J Vasc Surg"},{"key":"9113_CR26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2214\/ajr.183.4.1831021","volume":"183","author":"G Henkle","year":"2004","unstructured":"Henkle G, Kunz P, Funaki B (2004) Patterns of referral for inferior vena caval filtration: delays and their impact. AJR 183:1021\u20131024","journal-title":"AJR"},{"key":"9113_CR27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","volume":"338","author":"H Decousus","year":"1998","unstructured":"Decousus H, Leizorovicz A, Parent F, et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with deep venous thrombosis prevention du risque d\u2019embolie pulmonaire par interruption. Cave Study Group. N Engl J Med 338:409\u2013415","journal-title":"N Engl J Med"},{"key":"9113_CR28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.blre.2004.08.002","volume":"19","author":"CL Hann","year":"2005","unstructured":"Hann CL, Streiff MB (2005) The role of vena caval filters in the management of venous thromboembolism. Blood Rev 19:179\u2013202","journal-title":"Blood Rev"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-007-9113-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-007-9113-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-007-9113-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T19:45:06Z","timestamp":1587671106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-007-9113-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,29]]},"references-count":28,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["9113"],"URL":"https:\/\/doi.org\/10.1007\/s00270-007-9113-7","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,29]]}}}